Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
135.00
+3.00 (2.27%)
May 11, 2026, 3:13 PM IST
83.50% (1Y)
| Market Cap | 3.20B +85.0% |
| Revenue (ttm) | 1.47B -0.5% |
| Net Income | 96.61M +124.8% |
| EPS | 4.09 +125.1% |
| Shares Out | 23.66M |
| PE Ratio | 33.14 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,640 |
| Average Volume | 4,269 |
| Open | 133.99 |
| Previous Close | 132.00 |
| Day's Range | 126.70 - 136.00 |
| 52-Week Range | 71.57 - 202.06 |
| Beta | 0.18 |
| RSI | 53.75 |
| Earnings Date | May 26, 2026 |